Subscribe to RSS
Malignant Peripheral Nerve Sheath Scalp Tumor: A Short-Term Institutional Experience with Literature Review
Malignant peripheral nerve sheath tumor (MPNST) of the scalp is rare. These lesions are associated with neurofibromatosis type 1 (NF1), but patients had been reported without NF1 also. We tried to analyze the difference between the clinical course and outcome of the patient with MPNST having stigmata of NF1 and without it. We included five patients treated over 3 years between July 2018 and July 2021 with diffuse scalp MPNST. Two of these five patients with MPNST of the scalp had neurocutaneous stigmata of NF1. Three were female and two males with an average age of 38.40 ± 18.48 years—the youngest with NF1 being a 19-year-old female. We found dull aching pain as the most typical complaint in all patients and a repeated episode of generalized seizure in one patient. In these cases, two patients with NF1 have highly vascular tumors and attained large sizes greater than 30 cm. These two cases required preoperative digital subtraction angiography (DSA) and embolization with n-butyl acrylate. Total excision of the tumor was done in all patients with radiotherapy. Metastases within 1 year were noted in two patients with NF1, and one of these two succumbed to her illness. The rest of the three patients without NF1 are under follow-up with no evidence of disease with a maximum follow-up of 2 years. Large MPNST (size > 20 cm) are rare and reported to have been associated with and without NF1. Patients with scalp MPNST with NF1 can achieve larger size with fast progression of tumor size and higher chances of recurrence and metastases.
Keywordsmalignant peripheral nerve sheath tumor - diffuse scalp lesion - neurofibromatosis type 1 - clinical course - treatment outcome
Institutional ethical permission was obtained with IEC No. 441/2021.
The patient's relatives' consent was taken at the time of admission to use his data for teaching and research purposes.
Article published online:
27 March 2023
© 2023. Asian Congress of Neurological Surgeons. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
- 1 F. T, Amm A, Ba de L. et al. Giant malignant peripheral nerve sheath tumor of the scalp. Acta Neurol Taiwan 2012; 21 (03) 133-135
- 2 Mullins BT, Hackman T. Malignant peripheral nerve sheath tumors of the head and neck: a case series and literature review. Case Rep Otolaryngol 2014; 2014: 368920 DOI: 10.1155/2014/368920.
- 3 Cubas Farinha N, Belo D, Freitas H, Coiteiro D. Giant malignant peripheral nerve sheath tumor of the scalp: case report and review of the literature. World Neurosurg 2020; 138: 246-252 DOI: 10.1016/j.wneu.2020.03.039.
- 4 Arshi A, Tajudeen BA, St John M. Malignant peripheral nerve sheath tumors of the head and neck: Demographics, clinicopathologic features, management, and treatment outcomes. Oral Oncol 2015; 51 (12) 1088-1094
- 5 Firdaus M, Gill AS, Mukarramah DA. et al. Malignant peripheral nerve sheath tumor of the scalp: Two rare case reports. Surg Neurol Int 2018; 9: 102 . Published 2018 May 15. doi: DOI: 10.4103/sni.sni_196_17.
- 6 Wang J, Ou SW, Guo ZZ, Wang YJ, Xing DG. Microsurgical management of giant malignant peripheral nerve sheath tumor of the scalp: two case reports and a literature review. World J Surg Oncol 2013; 11: 269 DOI: 10.1186/1477-7819-11-269.
- 7 Fukushima S, Kageshita T, Wakasugi S. et al. Giant malignant peripheral nerve sheath tumor of the scalp. J Dermatol 2006; 33 (12) 865-868 DOI: 10.1111/j.1346-8138.2006.00197.x.
- 8 Ge P, Fu S, Lu L, Zhong Y, Qi B, Luo Y. Diffuse scalp malignant peripheral nerve sheath tumor with intracranial extension in a patient with neurofibromatosis type 1. J Clin Neurosci 2010; 17 (11) 1443-1444
- 9 Liu X, Li W, Yuan H, Gu W, Chen D. Surgical treatment of rare giant malignant tumors of the scalp: a report of 3 cases with different tumor types. Oncol Lett 2016; 12 (05) 3411-3416
- 10 Guo A, Liu A, Wei L, Song X. Malignant peripheral nerve sheath tumors: differentiation patterns and immunohistochemical features-a mini-review and our new findings. J Cancer 2012; 3: 303-309 DOI: 10.7150/jca.4179.
- 11 Garg A, Gupta V, Gaikwad SB. et al. Scalp malignant peripheral nerve sheath tumor (MPNST) with bony involvement and new bone formation: case report. Clin Neurol Neurosurg 2004; 106 (04) 340-344
- 12 Anghileri M, Miceli R, Fiore M. et al. Malignant peripheral nerve sheath tumors: prognostic factors and survival in a series of patients treated at a single institution. Cancer 2006; 107 (05) 1065-1074 DOI: 10.1002/cncr.22098.
- 13 Shintaku M, Wada K, Wakasa T, Ueda M. Malignant peripheral nerve sheath tumor with fibroblastic differentiation in a patient with neurofibromatosis type 1: imprint cytological findings. Acta Cytol 2011; 55 (05) 467-472 DOI: 10.1159/000330676.
- 14 Chen DW, Gu WH, Fu SL. Giant scalp malignant peripheral nerve sheath tumor: one case report [article in Chinese]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2011; 46 (12) 1047-1048
- 15 Gousias K, Boström J, Kovacs A, Niehusmann P, Wagner I, Kristof R. Factors of influence upon overall survival in the treatment of intracranial MPNSTs. Review of the literature and report of a case. Radiat Oncol 2010; 5 (01) 114 . DOI: DOI: 10.1186/1748-717X-5-114.
- 16 Kolberg M, Høland M, Agesen TH. et al. Survival meta-analyses for >1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1. Neuro-oncol 2013; 15 (02) 135-147 DOI: 10.1093/neuonc/nos287.
- 17 Evans DGR, Baser ME, McGaughran J, Sharif S, Howard E, Moran A. Malignant peripheral nerve sheath tumours in neurofibromatosis 1. J Med Genet 2002; 39 (05) 311-314 DOI: 10.1136/jmg.39.5.311.